Ranbaxy launches Valaciclovir tablets in US – 27th Nov 09

2009 November 27

Your Ad Here

Ranbaxy launches Valaciclovir tablets in US; Valtrex has annual sales of over $ 2 Bn in US; Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period: PharmAsiaNews
Ranbaxy launches Valaciclovir tablets in US reports CNBC TV18 quoting PharmAsiaNews.com. Valaciclovir is branded as Valtrex by GSK. Valtrex has annual sales of over $ 2 Bn in US. Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period. Ranbaxy has ‘First To File’ status for Valaciclovir.

Also Read :  New Mutual Fund Offers

Your Ad Here

No related posts.

Comments are closed for this entry.